Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Design Therapeutics, Inc. | 19,000 | reported | 10 Jun 2025 | tx 10+219,179 |
| Mirati Therapeutics, Inc. | 11,000 | reported | 17 Jan 2019 | tx 9+117,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2025 | GRANT_AWARD | Design Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Design Therapeutics, Inc. | 25,993 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Design Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 01 Dec 2023 | GRANT_AWARD | Design Therapeutics, Inc. | 69,186 | 0.00 USD | deriv |
| 29 Sept 2023 | PURCHASE | Design Therapeutics, Inc. | 21,000 | 2.35 USD | |
| 31 May 2023 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 09 Dec 2022 | PURCHASE | Design Therapeutics, Inc. | 15,000 | 7.96 USD | first after silence |
| 15 Jun 2022 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 30 Mar 2021 | PURCHASE | Design Therapeutics, Inc. | 5,000 | 20.00 USD | |
| 25 Mar 2021 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 17 Jan 2019 | GRANT_AWARD | Mirati Therapeutics, Inc. | 11,000 | 0.00 USD | deriv |
| 18 Jan 2018 | GRANT_AWARD | Mirati Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 17 May 2017 | GRANT_AWARD | Mirati Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 30 Mar 2017 | GRANT_AWARD | Mirati Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 18 May 2016 | GRANT_AWARD | Mirati Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 21 May 2015 | GRANT_AWARD | Mirati Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 09 Sept 2014 | GRANT_AWARD | Mirati Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 09 Sept 2014 | GRANT_AWARD | Mirati Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 09 Sept 2014 | GRANT_AWARD | Mirati Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 09 Dec 2022.